fda - Search News

News

US FDA approves twice-yearly injection for HIV prevention

Associated Press News on MSN · 17h

FDA approves the world’s only twice-a-year shot to prevent HIV

The Food and Drug Administration has approved the world’s only twice-a-year shot to prevent HIV. In two groundbreaking studies, Gilead Sciences’ shot nearly eliminated new infections in people at high risk of HIV.

USA TODAY on MSN · 16h

FDA approves new twice-yearly HIV shot. What to know

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections.

CNN on MSN · 17h

FDA approves twice-a-year injection for HIV prevention

A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug Administration to be used to prevent HIV. Gilead Sciences, maker of the drug,

US FDA to shorten review time for drug developers

The Baltimore Sun · 16h

FDA announces sweeping changes to speed up the drug review process

An FDA pilot program, known as the Commissioner’s Priority Voucher program, could drastically change the way pharmaceutical drugs reach the public and significantly cut down the time in

Associated Press News on MSN · 1d

FDA to offer faster drug reviews to companies promoting ‘national priorities’

The Food and Drug Administration says it will begin offering faster reviews to new medicines that align with Trump administration priorities for Americans' health.

Reuters on MSN · 1d

US FDA to shorten review time for drug developers under new voucher program

The U.S. FDA is launching a program under which its commissioner can issue vouchers to companies he finds are aligned with national priorities to shorten their review time for a drug application to one to two months from the typical timeline of about 10-12 months.

20h

FDA Offers Speedier Approvals to Drug Companies Aligning With 'National Priorities'

The initiative, referred to as the Commissioner's National Priority Voucher program, allows drug developers to participate in ...

The FDA Announced a Recall of This Children's Cough Syrup Dating Back to 2022

If you purchased the Little Remedies Honey Cough Syrup for your child, discontinue use immediately and contact the company ...

2d

FDA Issues Warning Over 'Gas Station Heroin' With Fatal Side Effects

U.S. cases of severe side effects from exposure to tianeptine have increased from 11 in total between 2000 and 2013 to 151 in ...

18hon MSN

US judge upholds FDA's removal of Ozempic, Wegovy from drug shortage list

A federal judge has rejected a bid by compounding pharmacies to allow them to continue making copies of Novo Nordisk's ...

Vinay Prasad named chief medical and science officer at FDA

Vinay Prasad is taking on several big roles at the FDA, solidifying his position as a top adviser to Commissioner Marty ...

Fierce Pharma18h

FDA signs off on Gilead’s landmark long-acting PrEP med, signaling new era in HIV prevention

With the FDA’s much-anticipated nod for Gilead Sciences’ long-acting HIV pre-exposure prophylaxis (PrEP) injection Yeztugo ...

23hon MSN

Coca-Cola recall update as FDA issues risk warning for contaminated drink

The U.S. Food and Drug Administration (FDA) has assigned its second most serious risk level, Class II, to a recall of Topo ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results